Quick Takeaways
- ORBIMED ADVISORS LLC filed SCHEDULE 13D/A for Traws Pharma, Inc. Common Stock (TRAW).
- Disclosed ownership: 12%.
- Date of event: 16 Apr 2026.
ORBIMED ADVISORS LLC - 16 Apr 2026 SCHEDULE 13D/A Report for Traws Pharma, Inc. Common Stock (TRAW)
- Filing Manager
- ORBIMED ADVISORS LLC
- Reporting Manager
- ORBIMED ADVISORS LLC
- Security
- Traws Pharma, Inc. Common Stock
- Symbol
- TRAW
- Shares outstanding
- 15,766,370 shares
- Disclosed Ownership
- 1,876,198 shares
- Ownership
- 12%
- Form type
- SCHEDULE 13D/A
- Filing time
- 05 May 2026, 18:55:40 UTC
- Date of event
- 16 Apr 2026
- Previous filing
- 29 Jan 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"ORBIMED ADVISORS LLC disclosed 12% ownership in Traws Pharma, Inc. Common Stock (TRAW) on 16 Apr 2026."
What Changed
- Previous schedule filing date: 29 Jan 2025.
- Current filing was accepted on 05 May 2026, 18:55.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 12% | 1,876,198 | 0 | 1,876,198 | /s/ Carl L. Gordon | Carl L. Gordon/Member | 0001055951 |
| OrbiMed Capital GP VIII LLC | 12% | 1,876,198 | 0 | 1,876,198 | /s/ Carl L. Gordon | Carl L. Gordon/Member of OrbiMed Advisors LLC | 0001845804 |